By Professor Kate Gemma Quinlan

Conference Papers

Kreissl M; Sandaradura SA; Dowling JJ; Kostyukova AS; Moroz N; Quinlan KG; Lehtokari V; Ravenscroft G; Todd EJ; Ceyhan-Birsoy O; Gokhin DS; Maluenda J; Lek M; Nolent F; Pappas CT; Novak SM; D’Amico A; Malfatti E; Thomas BP; Gabriel SB; Gupta N; Daly MJ; Ilkovski B; Houweling PJ; Swanson LC; Brownstein CA; Gupta VA; Medne L; Shannon P; Flisberg A; Holmberg E; Van den Bergh P; Lapunzina P; Waddell LB; Sloboda DD; Bertini E; Chitayat D; Telfer WR; Laquerrière A; Gregorio CC; Ottenheijm CAC; Bönnemann CG; Pelin K; Beggs AH; Hayashi YK; Romero NB; Laing NG; Nishino I; Wallgren-Pettersson C; Melki J; Fowler VM; MacArthur DG; North KN; Clarke NF, 2014, 'G.O.2 Mutations in LMOD3 cause severe nemaline myopathy by disrupting thin filament organisation in skeletal muscle', in Neuromuscular Disorders, Elsevier, pp. 792 - 793, http://dx.doi.org/10.1016/j.nmd.2014.06.010

Quinlan KGR; Seto JTC; Lek M; Zheng FX; Garton F; Houweling PJ; North KN, 2012, 'ACTN3 genotype influences skeletal muscle performance through alterations in calcineurin signaling', in NEUROMUSCULAR DISORDERS, PERGAMON-ELSEVIER SCIENCE LTD, AUSTRALIA, Perth, pp. 904 - 904, presented at 17th International Congress of the World-Muscle-Society (WMS), AUSTRALIA, Perth, 09 October 2012 - 13 October 2012, http://dx.doi.org/10.1016/j.nmd.2012.06.331

Quinlan KGR; Seto JT; Turner N; Floetenmeyer M; Macarthur DG; Raftery JM; Yang N; Parton RG; Cooney GJ; North KN, 2009, 'alpha-Actinin-3 regulates muscle glycogen phosphorylase: A potential mechanism for the metabolic consequences of the common human null allele of ACTN3', in NEUROMUSCULAR DISORDERS, PERGAMON-ELSEVIER SCIENCE LTD, SWITZERLAND, Geneva, pp. 545 - 546, presented at 14th International Congress of the World-Muscle-Society, SWITZERLAND, Geneva, 09 September 2009 - 12 September 2009, http://dx.doi.org/10.1016/j.nmd.2009.06.011

Back to profile page